Derivatives of rifamycin-SV with substituted cyclic-amine side chains in position 3 of the ansa ring are strong inhibitors of RNA-directed DNA and DNA-directed DNA polymerase activity of RNA tumor viruses of murine, feline, and avian origin. Among 37 3-amine derivatives of rifamycin-SV that were tested, 29 3-cyclic amine derivatives were good inhibitors of the viral polymerases. Especially active were 3-piperidyl derivatives of rifamycin-SV with cyclohexyl and cyclohexylalkyl substituents. Derivatives that were effective against the viral polymerase also blocked cell transformation by the murine sarcoma virus. A DNA-directed DNA polymerase preparation from human KB cells was less sensitive to inhibition by these derivatives than the virion polymerase.
Can chemotherapy of viral diseases and cancer be based on the control of replication of specific classes of nucleic acid molecules? The search for specific inhibitors of polymerase has an excellent start, for the antibiotic rifamycin-SV and several of its semisynthetic derivatives specifically bind to and block the DNA-directed RNA polymerase of bacteria. Although these derivatives do not inhibit mammalian polymerases (1) , we found that lengthening the rifampicin 3-iminomethyl4-methyl-1-piperazine side chain by substitution of benzyl for methyl yields compounds (Fig. 1 , AF/ABDMP and AB/ABP) that inhibit the RNA-directed DNA polymerase (reverse transcriptase) of RNA tumor viruses; removal of the methyl group yields N-demethyl rifampicin, a weak inhibitor (2) (3) (4) .
To see if even more extensive inhibition is possible, we have explored further the structural requirements for antipolymerase activity. We tested the ability of rifamycin-SV derivatives that contain 3-amine, quinoxalino, and benzoxazino substituents (see Fig. 1 ) to inhibit RNA-directed DNA and DNA-directed DNA polymerase. For investigation of DNA-directed DNA polymerase activity, the partially purified enzyme of the Harvey strain of murine sarcoma virus (MSV strain H) was tested with poly d(A-T) as a template. For RNA-directed DNA polymerase activity, the endogenous activity of the Moloney (M) strain of MSV was used. These polymerase activities of RNA tumor viruses are especially suitable for testing, since their true function during oncogenesis is probably DNA synthesis (2) (3) (4) , and, therefore, they are a natural target for possible chemotherapy.
MATERUILS AND METHODS
Viruses. Strains H and M of MSV, and FeLV were propagated in cultured cells and purified (2, 5, 6) . AMV, kindly provided by Dr. Joseph Beard, was purified as described (7) .
Rifamycin Derivatives. The rifamycin-SV derivatives used in this study were generously provided by Drs RESULTS For these studies, we tested four categories of rifamycin-SV derivatives as shown in Fig. 1 , 3-alkylamines, 3-cyclic amines, benzoxazino derivatives, and quinoxalino derivatives. Initial studies on eleven 3-amine derivatives (C1-C11, see below) and nine benzoxazino and quinoxalino derivatives led to more extensive analyses of 3-cyclic amine derivatives.
Inhibition of RNA-directed DNA and DNA-directed DNA polymerase of MSV by 3-amine, benzoxazino, and quinoxalino derivatives of rifamycin-SV At a concentration of 100 pg/ml, the simple 3-piperidyl derivative NQ (C7), inhibited polymerase activity.
However, derivatives with simple 3-alkyl amine substituents, -NH-C2H5 (Cl) and -N-(C2H5)2 (C2), 3-cyclic amines con- inactive or only weakly inhibitory (data not shown). Although the introduction of polar groups on the piperidyl ring, 3'-OH (C8) or 4'-CH20H (C9), abolished inhibitory activity, the addition of nonpolar substituents (C10 and C11, see Fig. 2 ) greatly enhanced inhibitory activity. A pronounced stimulation of activity was produced by C3, C8, and C9, suggesting that noninhibitory derivatives may bind to the polymerase and alter its conformation.
In contrast, of four benzoxazino and five quinoxalino derivatives tested, one of each was weakly inhibitory. These two derivatives and the two inhibitory 3-cyclic amines (C10 and C11) were tested further at concentrations of 5-100 ,ig/ml. The RNA-directed DNA polymerase of MSV strain M was inhibited by low concentrations of the 3-amine derivatives (over 50% was inhibited at 20 Mug), but required 100 Mug or more of quinoxalino and benzoxazino derivatives for significant inhibition (not shown). The data in Fig. 2 show that the purified DNA polymerase of MSV strain H was inhibited strongly by the 3-cyclic amine derivatives (over 99% at a concentration of 50 ,ug/ml and over 70% at 20 Ag/ml), but only moderately by the benzoxazino and quinoxalino derivatives. AF/ABDMP was as active as the benzoxazino and quinoxalino derivatives, while demethylrifampicin was inactive. In view of these encouraging results that suggested that inhibitory activity was enhanced by nonpolar groups, we tested 26 derivatives possessing either piperidine groups with large nonpolar substituents, or other bulky 3-cyclic amine derivatives ( Table 1 ). All of them inhibited both the DNAdirected DNA and RNA-directed DNA polymerase activity of MSV (Table 1) ; Five derivatives containing a cyclohexyl or cyclohexylalkyl substituent on the piperidine ring (C20, C22, C23, C27, and C31) were especially active, showing over 90% inhibition at a concentration of 20 Ag/ml.
Compared to piperidyl derivatives bearing a phenyl group (C19, C21, C30), the cyclohexyl-substituted piperidyl derivatives were 4-to 5-times more active (Fig. 3) . The seven most active inhibitors (C10, C11, C20, C22, C23, C27, and C31) inhibited the RNA-directed DNA polymerase of FeLV grown in human rhabdosarcoma cells (2) by 80-99% at a concentration of 100 Mg/ml, 50-91% at 50,Mg/ml, and 20-60% at 10 Mg/ml (not shown). Although a concentration of 100 Mg/ml of these same derivatives did not inhibit the RNA-directed DNA polymerase of AMV, 200 Mig/ml inhibited the activity by 60-99%. Penetration of these compounds into partially disrupted AMV is limiting since they inhibited purified AMV polymerase from 98 to 99.9% at a concentration of 100;Mg/ml (not shown). Three peaks of polymerase activity were observed. The peak that eluted at 0.12 M NaCl was frozen in 33% glycerol and used in the following experiment. 2 Biochemistry: Green et al.
3-Amine derivatives of rifamycin-SV inhibit cell transformation by MSV
The benzyl derivatives of rifampicin AF/ABDMP was reported to inhibit cell transformation by MSV (9) . Those 3-amine derivatives most active against the viral DNA polymerase inhibited MSV-induced cell transformation by 90-100%0 and 30-100% at concentrations of 10 ug/ml and 5 ;Lg/ml, respectively (Data with six of these are given in Those seven derivatives that inhibit both viral polymerase and cell transformation were tested against a partially purified DNA polymerase derived from human KB cells (Fig. 4) . Although all seven derivatives inhibited the DNA polymerase of KB cells, from 5-10 times higher concentrations were required to achieve the same percent inhibition that was observed with viral polymerase, under similar conditions.
DISCUSSION
Of 37 rifamycin-SV derivatives with 3-amine substituents, 29 were good inhibitors of both the RNA-directed DNA and DNA-directed DNA polymerase activities of RNA tumor viruses. The simplest inhibitor was the 3-piperidyl derivative of rifamycin-SV. The addition of nonpolar substituents to the piperidine ring markedly increased--the inhibitory activity; derivatives with cyclohexyl and cyclohexylalkyl substituents were 4-to 5-times more inhibitory than the analogous compounds with phenyl and phenylalkyl substituents. Cyclic amine derivatives with 5-or 7-membered rings were also active as inhibitors, but derivatives containing heteroatoms were inactive. The benzoxazino and quinoxalino derivatives were only weakly active.
Rifamycin derivatives are known that can discriminate among different polymerases (1) . The screening used thus far has been for extensiveness of inhibition and the results have shown derivatives that are potent against viral polymerases but still possess some activity against cell polymerases. Our data show a close correlation between the ability of 3-cyclicamine rifamycin-SV derivatives to inhibit DNA polymerases of RNA tumor viruses and to inhibit cell transformation.
Because of the nature of the derivatives used in these studies, the effect on cell transformation can be caused by inhibition of viral DNA polymerase, or of cell polymerase, or of both. If specific polymerases are involved in copying oncogenic information, whether of viral or cellular origin, it may be possible to obtain inhibitors specific for the recognition site of these polymerases.
